Viaatris pays up to $ 335 million in the Opiide agreement and refuses to make a mistake.

Viaatris will spend $ 335 million to solve the opioid -related claims for pharmaceutical companies based on Canosburg.

The nine -year agreement will come to nine annual payments between $ 27.5 million to $ 40 million to state and local governments. It will support opioid -related treatment and other efforts..

Viaatris (NASDAQ: VTRS) said in a statement published on Monday that the company’s presence in the US opioid market is very small, but the company has agreed to provide the closure of this problem. “This agreement is never a fault or hospitalization.”

Viaatris has become the latest pharmaceutical company to reach agreements with state, local governments and other countries for the opioid crisis. In the last few years, there have been about $ 50 billion settlement, and most recently, Purdue Pharma and its owner, Sackler Family, announced in January. PENNSYLVANIA will receive $ 222 million in Purdue Pharma/Sackler Settlement..

Click here to read more from the Pittsburgh Business Times partner.

Download Free WPXI News App To break the news alarm.

Follow the Channel 11 News Facebook and twitter. | Watch WPXI now